[HTML][HTML] Antioxidant Properties of oral antithrombotic therapies in atherosclerotic Disease and Atrial Fibrillation

L Falco, V Tessitore, G Ciccarelli, M Malvezzi… - Antioxidants, 2023 - mdpi.com
The thrombosis-related diseases are one of the leading causes of illness and death in the
general population, and despite significant improvements in long-term survival due to …

[HTML][HTML] Anti-inflammatory and anticancer effects of anticoagulant therapy in patients with malignancy

V Russo, L Falco, V Tessitore, A Mauriello, D Catapano… - Life, 2023 - mdpi.com
Optimizing the anticoagulation therapy is of pivotal importance in patients with a malignant
tumor, as venous thromboembolism (VTE) has become the second-leading cause of death …

[HTML][HTML] Gender differences in atrial fibrillation: from the thromboembolic risk to the anticoagulant treatment response

A Rago, C Pirozzi, A D'Andrea, P Di Micco, AA Papa… - Medicina, 2023 - mdpi.com
Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased
thromboembolic risk. The impact of the female sex as an independent risk factor for …

Effects of acute and long-term tachypacing on atrial engineered human myocardium

TJS Rubio - 2023 - ediss.uni-goettingen.de
First, I would like to express my gratitude towards Pr. Niels Voigt for welcoming me in his
team and for the opportunity he gave me with this thesis. Also, I'm truly grateful for his …

Povezanost mitralne regurgitacije s trombom u lijevom atriju bolesnika s fibrilacijom atrija

I Ivanac Vranešić - 2023 - repozitorij.unizg.hr
Sažetak Uvod i ciljevi rada: Fibrilacija atrija (FA) je najčešća postojana srčana aritmija koja
značajno povećava rizik od nastanka tromba u lijevom atriju (LAT). Dosadašnje studije o …

Edoxaban (LIXIANA®) in the treatment of venous thromboembolism

R Bottino, A Carbone, B Liccardo, A D'Andrea… - Future …, 2020 - Future Medicine
Standard therapy for venous thromboembolism (VTE) includes the use of heparins and
vitamin K antagonists. Randomized clinical trials have shown that non-vitamin K oral …

Pacjent wymagający terapii przeciwkrzepliwej w gabinecie lekarza POZ

R Roemer-Ślimak - Lekarz POZ - termedia.pl
Doustną antykoagulację stosuje się w zapobieganiu incydentom zakrzepowo-zatorowym i
leczeniu żylnej choroby zakrzepowo-zatorowej (ŻChZZ) od lat 50. ubiegłego wieku. W …